Brainstem and striatal encephalitis complicating mycoplasma pneumoniae pneumonia: possible benefit of intravenous immunoglobulinSAKOULAS, George.The Pediatric infectious disease journal. 2001, Vol 20, Num 5, pp 543-545, issn 0891-3668Article

Evaluating Aztreonam and Ceftazidime Pharmacodynamics with Escherzchia coli in Combination with Daptomycin, Linezolid, or Vancomycin in an In Vitro Pharmacodynamic ModelsLAPLANTE, Kerry L; SAKOULAS, George.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 10, pp 4549-4555, issn 0066-4804, 7 p.Article

Perspectives on Daptomycin Resistance, with Emphasis on Resistance in Staphylococcus aureusBOUCHER, Helen W; SAKOULAS, George.Clinical infectious diseases. 2007, Vol 45, Num 5, pp 601-608, issn 1058-4838, 8 p.Article

Daptomycin in Combination With Other Antibiotics for the Treatment of Complicated Methicillin-Resistant Staphylococcus aureus BacteremiaDHAND, Abhay; SAKOULAS, George.Clinical therapeutics. 2014, Vol 36, Num 10, pp 1303-1316, issn 0149-2918, 14 p.Article

Vancomycin Ototoxicity : a Reevaluation in an Era of Increasing DosesFOROUZESH, Avisheh; MOISE, Pamela A; SAKOULAS, George et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 2, pp 483-486, issn 0066-4804, 4 p.Article

A Current Perspective on Daptomycin for the Clinical MicrobiologistHUMPHRIES, Romney M; POLLETT, Simon; SAKOULAS, George et al.Clinical microbiology reviews (Print). 2013, Vol 26, Num 4, pp 759-780, issn 0893-8512, 22 p.Article

Efficacy and Safety of Daptomycin in Patients with Renal Impairment: A Multicenter Retrospective AnalysisKULLAR, Ravina; MCCLELLAN, Ian; GERIAK, Matthew et al.Pharmacotherapy. 2014, Vol 34, Num 6, pp 582-589, issn 0277-0008, 8 p.Conference Paper

Avoiding the Perfect Storm: The Biologic and Clinical Case for Reevaluating the 7-Day Expectation for Methicillin-Resistant Staphylococcus aureus Bacteremia Before Switching TherapyKULLAR, Ravina; MCKINNELL, James A; SAKOULAS, George et al.Clinical infectious diseases. 2014, Vol 59, Num 10, pp 1455-1461, issn 1058-4838, 7 p.Article

Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptionsMOISE, Pamela A; NORTH, Donald; STEENBERGEN, Judith N et al.Lancet. Infectious diseases (print). 2009, Vol 9, Num 10, pp 617-624, issn 1473-3099, 8 p.Article

Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureusSAKOULAS, George; ELIOPOULOS, George M; ALDER, Jeff et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 5, pp 1714-1718, issn 0066-4804, 5 p.Article

Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremiaMOISE, Pamela A; SAKOULAS, George; FORREST, Alan et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 7, pp 2582-2586, issn 0066-4804, 5 p.Article

Loss of vancomycin bactericidal activity against accessory gene regulator (agr) dysfunctional Staphylococcus aureus under conditions of high bacterial densityTSUJI, Brian T; HARIGAYA, Yoriko; LESSE, Alan J et al.Diagnostic microbiology and infectious disease. 2009, Vol 64, Num 2, pp 220-224, issn 0732-8893, 5 p.Article

Correlation of vancomycin and daptomycin susceptibility in staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and functionROSE, Warren E; RYBAK, Michael J; TSUJI, Brian T et al.Journal of antimicrobial chemotherapy (Print). 2007, Vol 59, Num 6, pp 1190-1193, issn 0305-7453, 4 p.Article

Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapySAKOULAS, George; MOELLERING, Robert C; ELIOPOULOS, George M et al.Clinical infectious diseases. 2006, Vol 42, issn 1058-4838, S40-S50, SUP1Article

Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in staphylococcus aureusTSUJI, Brian T; RYBAK, Michael J; LAU, Kerry L et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 3, pp 1089-1091, issn 0066-4804, 3 p.Article

Reduced Susceptibility to Host-Defense Cationic Peptides and Daptomycin Coemerge in Methicillin-Resistant Staphylococcus aureus From Daptomycin-Naive Bacteremic PatientsMISHRA, Nagendra N; BAYER, Arnold S; MOISE, Pamela A et al.The Journal of infectious diseases. 2012, Vol 206, Num 8, pp 1160-1167, issn 0022-1899, 8 p.Article

β-Lactam Antibiotics Targeting PBP1 Selectively Enhance Daptomycin Activity against Methicillin-Resistant Staphylococcus aureusBERTI, Andrew D; SAKOULAS, George; NIZET, Victor et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 10, pp 5005-5012, issn 0066-4804, 8 p.Article

Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycinSAKOULAS, George; ALDER, Jeff; THAUVIN-ELIOPOULOS, Claudie et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 4, pp 1581-1585, issn 0066-4804, 5 p.Article

Hematogenous enterococcal vertebral osteomyelitis: report of 2 cases and review of the literatureTARR, Philip E; SAKOULAS, George; GANESAN, Anuradha et al.The Journal of infection. 2004, Vol 48, Num 4, pp 354-362, issn 0163-4453, 9 p.Article

Ceftaroline Restores Daptomycin Activity against Daptomycin-Nonsusceptible Vancomycin-Resistant Enterococcus faeciumSAKOULAS, George; ROSE, Warren; NONEJUIE, Poochit et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 3, pp 1494-1500, issn 0066-4804, 7 p.Article

Treatment of High-Level Gentamicin-Resistant Enterococcus faecalis Endocarditis with Daptomycin plus CeftarolineSAKOULAS, George; NONEJUIE, Poochit; NIZET, Victor et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 8, pp 4042-4045, issn 0066-4804, 4 p.Article

Teicoplanin pharmacodynamics in reference to the accessory gene regulator (agr) in Staphylococcus aureus using an in vitro pharmacodynamic modelROSE, Warren E; KAATZ, Glenn W; SAKOULAS, George et al.Journal of antimicrobial chemotherapy (Print). 2008, Vol 61, Num 5, pp 1099-1102, issn 0305-7453, 4 p.Article

Increasing Antibiotic Resistance among Methicillin-Resistant Staphylococcus aureus StrainsSAKOULAS, George; MOELLERING, Robert C.Clinical infectious diseases. 2008, Vol 46, issn 1058-4838, S360-S367, SUP5Article

Clinical Outcomes of Patients Receiving Daptomycin for the Treatment of Staphylococcus aureus Infections and Assessment of Clinical Factors for Daptomycin Failure: A Retrospective Cohort Study Utilizing the Cubicin^® Outcomes Registry and ExperienceSAKOULAS, George; BROWN, Jack; LAMP, Kenneth C et al.Clinical therapeutics. 2009, Vol 31, Num 9, pp 1936-1945, issn 0149-2918, 10 p.Article

Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic ModelWERTH, Brian J; SAKOULAS, George; ROSE, Warren E et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 1, pp 66-73, issn 0066-4804, 8 p.Article